Review



high-density three-dimensional electroanatomic mapping system rhythmia  (Boston Scientific Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Boston Scientific Corporation high-density three-dimensional electroanatomic mapping system rhythmia
    High Density Three Dimensional Electroanatomic Mapping System Rhythmia, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic mapping system rhythmia/product/Boston Scientific Corporation
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic mapping system rhythmia - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    high-density three-dimensional electroanatomic map carto3  (Biosense Webster)
    90
    Biosense Webster high-density three-dimensional electroanatomic map carto3
    High Density Three Dimensional Electroanatomic Map Carto3, supplied by Biosense Webster, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic map carto3/product/Biosense Webster
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic map carto3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    high-density three-dimensional electroanatomic mapping system carto 3  (Biosense Webster)
    90
    Biosense Webster high-density three-dimensional electroanatomic mapping system carto 3
    High Density Three Dimensional Electroanatomic Mapping System Carto 3, supplied by Biosense Webster, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic mapping system carto 3/product/Biosense Webster
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic mapping system carto 3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    high-density three-dimensional electroanatomic mapping system ensite precision  (Abbott Laboratories)
    90
    Abbott Laboratories high-density three-dimensional electroanatomic mapping system ensite precision
    High Density Three Dimensional Electroanatomic Mapping System Ensite Precision, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic mapping system ensite precision/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic mapping system ensite precision - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    high-density three-dimensional electroanatomic mapping system rhythmia  (Boston Scientific Corporation)
    90
    Boston Scientific Corporation high-density three-dimensional electroanatomic mapping system rhythmia
    High Density Three Dimensional Electroanatomic Mapping System Rhythmia, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic mapping system rhythmia/product/Boston Scientific Corporation
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic mapping system rhythmia - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    high-density three-dimensional electroanatomic mapping coherent and ripple mapping carto ® 3  (Biosense Webster)
    90
    Biosense Webster high-density three-dimensional electroanatomic mapping coherent and ripple mapping carto ® 3
    High Density Three Dimensional Electroanatomic Mapping Coherent And Ripple Mapping Carto ® 3, supplied by Biosense Webster, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic mapping coherent and ripple mapping carto ® 3/product/Biosense Webster
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic mapping coherent and ripple mapping carto ® 3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    high-density three-dimensional electroanatomic mapping  (Boston Scientific Corporation)
    90
    Boston Scientific Corporation high-density three-dimensional electroanatomic mapping
    Experimental protocol and delivery technique. (A) Myocardial infarction was induced by 90 min balloon occlusion of the proximal anterior descending branch of the left coronary artery followed by 8 weeks of reperfusion. Cardiac function and scar size were examined by magnetic resonance imaging. Arrhythmia inducibility was probed by programmed electrical stimulation at the left ventricular scar border. If no sustained arrhythmia was induced, programmed electrical stimulation was repeated at the right ventricular apex. High-density three-dimensional <t>electroanatomic</t> mapping was then performed (Rhythmia®, Boston Scientific). Inducible animals were randomly assigned to receive focal injections of either 7.5 mg of CDCEXO in 2 mL of IMDM or 2 mL of IMDM alone. Injections were performed in areas where late potentials were identified using electroanatomical mapping and confirmed by point-by-point mapping (NOGA®, Biosense Webster). Magnetic resonance imaging, electroanatomical mapping, and programmed electrical stimulation were repeated 2 weeks later. Animals were then euthanized, and the heart was removed for histologic and proteomic analysis. (B: Left) High-definition electroanatomical mapping image of the arrhythmogenic substrate with an identified late potential. (Centre) Schematic representation of delivery technique using intracardiac injection catheter (Myostar®, Biosense Webster). (Right) Representative NOGA® map with injection sites (black dots). (C) Animals injected with vehicle alone showed diminished contractile function (CDCEXO 3.11 ± 3.75% vs. control −4.7 ± 4.04%, P = 0.0006). (D) Cardiac output increased in CDCEXO pigs (CDCEXO 278.1 ± 414 mL/min vs. control −586 ± 605 mL/min, P = 0.0027). (E) Deleterious changes in end-systolic volumes (CDCEXO −1.4 ± 3.3 mL vs. control 8 ± 8.2 mL, P = 0.005) were observed in control but not in CDCEXO pigs. A two-tailed t-test was used to compare the changes between groups.
    High Density Three Dimensional Electroanatomic Mapping, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic mapping/product/Boston Scientific Corporation
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic mapping - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    high-density three-dimensional electroanatomic map  (Biosense Webster)
    90
    Biosense Webster high-density three-dimensional electroanatomic map
    Experimental protocol and delivery technique. (A) Myocardial infarction was induced by 90 min balloon occlusion of the proximal anterior descending branch of the left coronary artery followed by 8 weeks of reperfusion. Cardiac function and scar size were examined by magnetic resonance imaging. Arrhythmia inducibility was probed by programmed electrical stimulation at the left ventricular scar border. If no sustained arrhythmia was induced, programmed electrical stimulation was repeated at the right ventricular apex. High-density three-dimensional <t>electroanatomic</t> mapping was then performed (Rhythmia®, Boston Scientific). Inducible animals were randomly assigned to receive focal injections of either 7.5 mg of CDCEXO in 2 mL of IMDM or 2 mL of IMDM alone. Injections were performed in areas where late potentials were identified using electroanatomical mapping and confirmed by point-by-point mapping (NOGA®, Biosense Webster). Magnetic resonance imaging, electroanatomical mapping, and programmed electrical stimulation were repeated 2 weeks later. Animals were then euthanized, and the heart was removed for histologic and proteomic analysis. (B: Left) High-definition electroanatomical mapping image of the arrhythmogenic substrate with an identified late potential. (Centre) Schematic representation of delivery technique using intracardiac injection catheter (Myostar®, Biosense Webster). (Right) Representative NOGA® map with injection sites (black dots). (C) Animals injected with vehicle alone showed diminished contractile function (CDCEXO 3.11 ± 3.75% vs. control −4.7 ± 4.04%, P = 0.0006). (D) Cardiac output increased in CDCEXO pigs (CDCEXO 278.1 ± 414 mL/min vs. control −586 ± 605 mL/min, P = 0.0027). (E) Deleterious changes in end-systolic volumes (CDCEXO −1.4 ± 3.3 mL vs. control 8 ± 8.2 mL, P = 0.005) were observed in control but not in CDCEXO pigs. A two-tailed t-test was used to compare the changes between groups.
    High Density Three Dimensional Electroanatomic Map, supplied by Biosense Webster, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic map/product/Biosense Webster
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic map - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    high-density three-dimensional electroanatomic map carto  (Biosense Webster)
    90
    Biosense Webster high-density three-dimensional electroanatomic map carto
    Experimental protocol and delivery technique. (A) Myocardial infarction was induced by 90 min balloon occlusion of the proximal anterior descending branch of the left coronary artery followed by 8 weeks of reperfusion. Cardiac function and scar size were examined by magnetic resonance imaging. Arrhythmia inducibility was probed by programmed electrical stimulation at the left ventricular scar border. If no sustained arrhythmia was induced, programmed electrical stimulation was repeated at the right ventricular apex. High-density three-dimensional <t>electroanatomic</t> mapping was then performed (Rhythmia®, Boston Scientific). Inducible animals were randomly assigned to receive focal injections of either 7.5 mg of CDCEXO in 2 mL of IMDM or 2 mL of IMDM alone. Injections were performed in areas where late potentials were identified using electroanatomical mapping and confirmed by point-by-point mapping (NOGA®, Biosense Webster). Magnetic resonance imaging, electroanatomical mapping, and programmed electrical stimulation were repeated 2 weeks later. Animals were then euthanized, and the heart was removed for histologic and proteomic analysis. (B: Left) High-definition electroanatomical mapping image of the arrhythmogenic substrate with an identified late potential. (Centre) Schematic representation of delivery technique using intracardiac injection catheter (Myostar®, Biosense Webster). (Right) Representative NOGA® map with injection sites (black dots). (C) Animals injected with vehicle alone showed diminished contractile function (CDCEXO 3.11 ± 3.75% vs. control −4.7 ± 4.04%, P = 0.0006). (D) Cardiac output increased in CDCEXO pigs (CDCEXO 278.1 ± 414 mL/min vs. control −586 ± 605 mL/min, P = 0.0027). (E) Deleterious changes in end-systolic volumes (CDCEXO −1.4 ± 3.3 mL vs. control 8 ± 8.2 mL, P = 0.005) were observed in control but not in CDCEXO pigs. A two-tailed t-test was used to compare the changes between groups.
    High Density Three Dimensional Electroanatomic Map Carto, supplied by Biosense Webster, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-density three-dimensional electroanatomic map carto/product/Biosense Webster
    Average 90 stars, based on 1 article reviews
    high-density three-dimensional electroanatomic map carto - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Experimental protocol and delivery technique. (A) Myocardial infarction was induced by 90 min balloon occlusion of the proximal anterior descending branch of the left coronary artery followed by 8 weeks of reperfusion. Cardiac function and scar size were examined by magnetic resonance imaging. Arrhythmia inducibility was probed by programmed electrical stimulation at the left ventricular scar border. If no sustained arrhythmia was induced, programmed electrical stimulation was repeated at the right ventricular apex. High-density three-dimensional electroanatomic mapping was then performed (Rhythmia®, Boston Scientific). Inducible animals were randomly assigned to receive focal injections of either 7.5 mg of CDCEXO in 2 mL of IMDM or 2 mL of IMDM alone. Injections were performed in areas where late potentials were identified using electroanatomical mapping and confirmed by point-by-point mapping (NOGA®, Biosense Webster). Magnetic resonance imaging, electroanatomical mapping, and programmed electrical stimulation were repeated 2 weeks later. Animals were then euthanized, and the heart was removed for histologic and proteomic analysis. (B: Left) High-definition electroanatomical mapping image of the arrhythmogenic substrate with an identified late potential. (Centre) Schematic representation of delivery technique using intracardiac injection catheter (Myostar®, Biosense Webster). (Right) Representative NOGA® map with injection sites (black dots). (C) Animals injected with vehicle alone showed diminished contractile function (CDCEXO 3.11 ± 3.75% vs. control −4.7 ± 4.04%, P = 0.0006). (D) Cardiac output increased in CDCEXO pigs (CDCEXO 278.1 ± 414 mL/min vs. control −586 ± 605 mL/min, P = 0.0027). (E) Deleterious changes in end-systolic volumes (CDCEXO −1.4 ± 3.3 mL vs. control 8 ± 8.2 mL, P = 0.005) were observed in control but not in CDCEXO pigs. A two-tailed t-test was used to compare the changes between groups.

    Journal: European Heart Journal

    Article Title: Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy

    doi: 10.1093/eurheartj/ehac042

    Figure Lengend Snippet: Experimental protocol and delivery technique. (A) Myocardial infarction was induced by 90 min balloon occlusion of the proximal anterior descending branch of the left coronary artery followed by 8 weeks of reperfusion. Cardiac function and scar size were examined by magnetic resonance imaging. Arrhythmia inducibility was probed by programmed electrical stimulation at the left ventricular scar border. If no sustained arrhythmia was induced, programmed electrical stimulation was repeated at the right ventricular apex. High-density three-dimensional electroanatomic mapping was then performed (Rhythmia®, Boston Scientific). Inducible animals were randomly assigned to receive focal injections of either 7.5 mg of CDCEXO in 2 mL of IMDM or 2 mL of IMDM alone. Injections were performed in areas where late potentials were identified using electroanatomical mapping and confirmed by point-by-point mapping (NOGA®, Biosense Webster). Magnetic resonance imaging, electroanatomical mapping, and programmed electrical stimulation were repeated 2 weeks later. Animals were then euthanized, and the heart was removed for histologic and proteomic analysis. (B: Left) High-definition electroanatomical mapping image of the arrhythmogenic substrate with an identified late potential. (Centre) Schematic representation of delivery technique using intracardiac injection catheter (Myostar®, Biosense Webster). (Right) Representative NOGA® map with injection sites (black dots). (C) Animals injected with vehicle alone showed diminished contractile function (CDCEXO 3.11 ± 3.75% vs. control −4.7 ± 4.04%, P = 0.0006). (D) Cardiac output increased in CDCEXO pigs (CDCEXO 278.1 ± 414 mL/min vs. control −586 ± 605 mL/min, P = 0.0027). (E) Deleterious changes in end-systolic volumes (CDCEXO −1.4 ± 3.3 mL vs. control 8 ± 8.2 mL, P = 0.005) were observed in control but not in CDCEXO pigs. A two-tailed t-test was used to compare the changes between groups.

    Article Snippet: High-density three-dimensional electroanatomic mapping was then performed (Rhythmia ® , Boston Scientific).

    Techniques: Magnetic Resonance Imaging, Injection, Control, Two Tailed Test